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Abstract Introduction and Meth-
ods: This report summarizes the
results of the first phase in the
development of international guide-
lines for death determination,
focusing on the biology of death and
the dying process, developed by an
invitational forum of international
content experts and representatives of
a number of professional societies.
Results and Conclusions: Precise
terminology was developed in order
to improve clarity in death discussion
and debate. Critical events in the
physiological sequences leading to
cessation of neurological and/or cir-
culatory function were constructed. It
was agreed that death determination
is primarily clinical and recommen-
dations for preconditions,
confounding factors, minimum clini-
cal standards and additional testing
were made. A single operational
definition of human death was
developed: ‘the permanent loss of
capacity for consciousness and all
brainstem functions, as a consequence
of permanent cessation of circulation
or catastrophic brain injury’. In order
to complete the project, in the next
phase, a broader group of interna-
tional stakeholders will develop
clinical practice guidelines, based on
comprehensive reviews and grading
of the existing evidence.
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Philosophical, religious, and cultural differences in the
concept of death and ways it is defined make discussions
of the subject very complex. Advances in medicine and
technology that have made it possible to support, repair,
or replace failing organs challenge commonly held
notions of life and death. The lack of understanding or
even awareness among the public [1] and health profes-
sionals [2] and the emotionally charged nature of the
subject further complicate discussions. Finally, the
determination of death is deeply entwined with organ
transplantation. The growing disparity between the
demand for and the availability of transplantable organs is
a public health concern globally [3]. In comparison to
bridge technologies for end-stage organ failure, such as
kidney dialysis [4] and ventricular assist devices [5],
organ transplantation is life-preserving, life-enhancing,
and cost-effective. Yet, when the supply of transplantable
organs falls short of demand, unethical and illegal
behaviours sometimes occur, including commercial organ
trade that victimizes the vulnerable [6], human killing as a
source of transplantable organs [7], and violations of the
allocation system [8].
While the public supports organ donation after death,
its credibility requires clarity in practice and policy.
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Depending on the country and related professional soci-
eties, guidelines may or may not exist for the
determination of death by neurological and/or circulatory
criteria, and when guidelines are in place, they have not
always been implemented in a manner that alleviates
concerns about the legitimacy of deceased organ dona-
tion. The situation is complicated by variations related to
the stage of development of a country’s deceased dona-
tion program and more generally by the significant
diversity in health services and standards of care world-
wide. The World Health Organization (WHO) and The
Transplantation Society (TTS) have received requests
from a number of countries to address these gaps and to
provide guidance to inform clinical practices and health
policy for death determination as part of an international
effort in support of the Istanbul Declaration [9], the WHO
Madrid Resolution [10], and the WHO Guiding Principles
on Human Cell, Tissue and Organ Transplantation,
approved by the World Health Assembly in 2010 [11]. An
international consensus on the determination of death
could provide a number of benefits including promoting
evidence-based practices, protecting the rights of both
patients and health care professionals, improving public
and professional confidence in the process of deceased
donation, and increasing the number of organs obtained in
an ethically legitimate fashion.
Methods
On 30–31 May 2012, an invitational forum sponsored by
Health Canada and Canadian Blood Services in collabo-
ration with the WHO was held in Montreal, Canada, as
part of the planning, scoping, and needs assessment phase
in the process of guideline development (see ‘‘Appendix
1’’ for forum committees and participants). The 32 invited
participants included delegates from a broad range of
national and international professional societies involved
with death determination in adults and children in acute
care settings. Prior to the forum, participants were pro-
vided with comprehensive background materials,
including a selected bibliography of peer-reviewed arti-
cles related to death determination, a literature review on
definitions of death, and a draft lexicon of medical ter-
minology relevant to death determination policy and
practice. Each section of the meeting began with an
expert speaker who provided historical information,
reviewed baseline knowledge, and supplied his or her
perspective on current issues and controversies. After
each presentation, participants asked questions of the
expert and discussed the presentation with the entire
group. Reference sheets that offered condensed summa-
ries of existing evidence were distributed, and the
participants were then divided into groups where they
held extensive discussions about a ‘‘challenge question’’
relevant to the topic of the session. When the participants
reconvened in the plenary, each group’s results were
discussed, and the collective outputs were reworked until
consensus was reached. Consensus was defined as
achieving substantial agreement, manifested by all par-
ticipants indicating that they agreed with or could accept a
conclusion, which they would support both within and
outside the meeting.
For the purposes of this forum, death was fundamen-
tally considered a biological event. While it was
respectfully recognized that legal, ethical, cultural, and
religious perspectives on death can impact the utility of
recommendations in the field, these perspectives were not
topics for debate or discussion at this initial meeting.
Table 1 highlights the common terminology that was
agreed upon to support clarity and precision in the lan-
guage used throughout this forum and for subsequent
phases of work. The planning committee worked with
participants to identify critical events that comprise the
dying sequence, with the understanding that dying is a
process whereby biological/physiological functions cease.
Death is an event in that dying process, a point when the
person can be determined to have died. The forum iden-
tified the tests required for the minimum acceptable
clinical standard for determining death in adults and
children and recommended additional testing beyond the
minimum standard. A consensus on an operational defi-
nition of human death was then derived.
Findings
Neurological sequence in the dying process
Forum participants identified several major sequential
events in the dying process of patients who have suffered
a catastrophic brain injury that will lead to death deter-
mined on a neurological basis (such as, but not limited to,
traumatic brain injury, cerebrovascular accidents, and
hypoxic-ischaemic encephalopathy after resuscitated
cardiac arrest) (Fig. 1). This sequence does not apply to
patients with anencephaly or with forms of catastrophic
brain injury (such as persistent vegetative states) where
residual clinical brain or brainstem functions are retained;
such patients were not under consideration. Patients
entering this sequence are receiving mechanical ventila-
tion; various other neuroprotective interventions (such as
hyperosmolar therapy, ventricular drainage, decompres-
sive craniectomy) may have been initiated as well. At
N-1, the patient continues to deteriorate in spite of
intervention and the treatment team recognizes that the
patient may evolve to brain death. At N-2, the deterio-
ration has continued to a point that brain function has
ceased. However, at this point it is still possible that brain
function could return spontaneously or be restored
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Table 1 Participants agreed to the following terminology, in order to improve the clarity of discussions and debate, for use during and
subsequent to this forum
Term Definition
Activity Physiologic properties of cells and groups of cells that can be measured by laboratory means
Asystole—electrical A condition characterized by the absence of electrical, and hence mechanical, activity of the heart,
resulting in the absence of contractions of the myocardium and cardiac output/anterograde blood
flow
Asystole—mechanical The absence of effective contractions of the myocardium and no cardiac output/anterograde blood
flow. May occur in the presence of an organized or disorganized electrocardiac rhythm, e.g.
pulseless electrical activity
Autoresuscitation The spontaneous resumption of heart contractions causing anterograde circulation that is not
induced by cardiopulmonary resuscitation or other external assistance. Examples of heart
function such as effective contractions of the myocardium leading to anterograde flow of blood
through the aorta and arterial system should be distinguished from examples of heart activity
such as atrial natriuretic hormone release or residual pulseless electrical activity
Brain death Diagnosis and confirmation of death based on the irreversible cessation of functioning of the entire
brain, including the brainstem (this forum supports the movement away from this traditional and
imprecise terminology in favour of the cessation of neurological function)
Brainstem death Diagnosis and confirmation of death based on the irreversible cessation of functioning of the
brainstem, predominantly but not exclusively secondary to a supratentorial brain injury (this
forum supports the movement away from this traditional and imprecise terminology in favour of
the cessation of neurological function)
Cardiac arrest The abrupt cessation of circulation of the blood due to failure of the heart to contract effectively.
Also known as cardiorespiratory arrest, cardiopulmonary arrest, or circulatory arrest
Catastrophic brain injury
leading to death
Etiologies of high severity that are common causes of brain death, such as, but not limited to,
traumatic brain injury, cerebrovascular accidents, and hypoxic-ischaemic encephalopathy after
resuscitated cardiac arrest
Other forms of catastrophic brain injury that have any degree of residual clinical brain or brainstem
function are not under consideration and may include persistent vegetative states, permanent
vegetative states, anencephaly, or those conditions related to the historical concept of higher
brain (cortical) death
Cerebral electrical activity Electrical activity of the brain, as measured using an electroencephalogram (EEG)
Cessation Stoppage, termination
Circulation Anterograde flow of blood through the aorta and arterial system
Circulatory death
determination
Diagnosis and confirmation of death based on circulatory criteria. Also known as death after cardiac
arrest, or death after cardiocirculatory arrest, or death after circulatory-respiratory determination
(this forum supports the movement away from this traditional and imprecise terminology in
favour of the cessation of circulatory function)
Clinical Based on direct, measurable observation or examination of the patient
Coma Prolonged absence of wakefulness, awareness, and the capacity for sensory perception or
responsiveness to the external environment
Confounding conditions Circumstances during which a diagnostic test may become unreliable and require repetition over
time or application of an alternative test
Consciousness—loss of
capacity for
Lack of current or any future potential for awareness, wakefulness, interaction and capacity for
sensory perception of, or responsiveness to the external environment
Criteria—minimum Refers to the lowest acceptable standard. The standard recommended by this forum sets the
minimum clinical criteria
Dead donor rule A principle governing deceased donation practices stating that vital organs should only be taken
from dead patients and, correlatively, living patients must not be killed by organ retrieval. This
rule does not apply to, nor preclude, living donation of non-vital organs
Death The moment in time during the dying process when the individual passes from the state of being
alive to that of being dead
Death—concept of An abstract, unprovable explanation of death, generally based on religious, spiritual, or
philosophical beliefs
Death—declaration of The point in time at which a health professional, having determined that an individual is dead,
formally states this finding
Death—operational
definition of
Biomedical criteria that describe the state of human death
Death—determination of Processes and tests required to diagnose death in accordance with established criteria
Disintegration Loss of intactness, solidness, or cohesion. Such loss can apply to function or to matter (tissues, etc.)
Dying The process whereby biological/physiological functions cease, thus moving from the state of being
alive to that of being dead
ECMO Extracorporeal membrane oxygenation/extracorporeal oxygenation and circulation of blood
deployed for life-threatening lung or heart–lung failure
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through intervention. If preconditions are met, con-
founding factors are absent, and no effective treatment is
available or implemented, then by N-3, the brain has
ceased functioning and there is no possibility to resume.
The patient has died.
Preconditions prior to testing brain function at any
point in the sequence include an established etiology;
absence of reversible etiologies that would explain the
coma; and the absence of hemodynamic shock associated
with inadequate oxygenated circulation to the brain [12].
Confounding conditions that may invalidate testing for
cessation of brain function include naturally occurring or
therapeutic hypothermia; the presence of central nervous
system (CNS) depressing drugs that may explain or
contribute to coma; high cervical spine injury; acquired
(such as severe polyneuropathy) or therapeutic neuro-
muscular paralysis; locked-in syndromes; and severe
acid-base, electrolyte or endocrine abnormalities that may
explain or contribute to coma [13]. After agreeing that
death is principally established using clinical criteria
(defined as diagnostic testing based on direct, measurable
observation or examination of the patient; see Table 1),
participants came to consensus on the ‘‘minimum





A form of mechanical asystole. A rhythm frequently encountered during cardiac arrest,
characterized by organized electrical activity without circulation, traditionally measured by the
absence of a palpable pulse or pulsatile arterial blood pressure
Fixed dilated pupils Pupils in mid-position or greater and unreactive to light
Function In the context of organs, the primary and fundamental purpose of that organ that can be assessed by
observation and examination and is necessary for sustained life. Function should be distinguished
from activities, as defined by physiologic properties of cells and groups of cells that can be
measured by laboratory means. Examples of brain function such as the capacity for
consciousness or ability for unassisted breathing should be distinguished from examples of brain
activity such as posterior pituitary antidiuretic hormone release or residual nests of neuronal
electrical activity
Integration Combined or coordinated separate elements that provide a harmonious, interrelated whole;
organized or structured so that constituent units function cooperatively
Irreversible Pertaining to a situation or condition that will not or cannot return or resume. In the context of death
determination, there are variable definitions including:
1. Loss of function or a condition that cannot be restored by anyone under any circumstances at a
time now or in the future
2. Loss of function or a condition that cannot be restored by those present at the time
3. Loss of function or a condition that will not resume and will not be restored. Also referred to as
permanent
Neuroimaging Diagnostic brain imaging techniques to identify structural brain injury, e.g. CT scan, MRI
Neurological death
determination
Diagnosis and confirmation of death based on neurological criteria
No effective intervention A therapeutic intervention that is not deployed because it is not effective, not medically indicated
under those circumstances, not available or accessible
Mechanical ventilation Assisted ventilation including bag/mask ventilation, non-invasive support e.g. BiPAP (bilevel
positive airway pressure), conventional mechanical ventilation via artificial airway
Refractory to treatment Does not respond to intervention in a clinically meaningful manner
Permanent Pertaining to a situation or condition that will not return to its previous state. In the context of death
determination, refers to loss of function that will not resume spontaneously and will not be
restored through intervention
Preconditions Patient-related prerequisites that should be fulfilled prior to application of diagnostic tests
Respiratory arrest Cessation of breathing. In the context of death discussions, this may be primary and lead to a
subsequent cardiac arrest, or it may be secondary to the loss of brainstem function
Test A procedure performed in diagnosis or detection
Test—ancillary A complementary test or an alternative test to one that otherwise, for any reason, cannot be
conducted or is unreliable
Test—clinical A bedside test typically based on physical examination of the patient, but may include the use of a
stethoscope and vital signs monitors
Test—confirmatory A test performed to confirm a previously conducted test
Test—laboratory A technical test requiring use of elaborate equipment and medical technologies, e.g. blood testing,
diagnostic imaging
Test—supplemental A test performed in addition to an already conducted test
Unity The combination or arrangement of parts into a whole
Ventricular fibrillation A condition in which there is uncoordinated contraction of the cardiac muscle of the ventricles that
causes the cessation of circulation. Also referred to as V-fib or VF
Vital function Necessary for sustained life
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brain function (Table 2). It was also agreed that the
validity of a determination of death depends upon the
health care professionals performing the clinical
determination and those performing and interpreting
ancillary laboratory testing possessing the necessary
competencies.
Circulatory sequence in the dying process
Forum participants identified several major sequential
events in the dying process of patients who suffer a cir-
culatory arrest (Fig. 2). In situation A, the patient has had
a cardiac arrest but no CPR intervention, either because
CPR was not medically indicated or the patient (or sur-
rogate decision maker) declined it; this would include
terminally ill patients whose end-of-life care involves
limiting or withdrawing life-sustaining therapies. At C-1,
the patient’s circulation and breathing stop. After a certain
time period (between 2 and 5 min, based on expert
consensus) [14], autoresuscitation-the spontaneous,
unassisted resumption of circulation-is no longer a pos-
sibility under these conditions (C-2). There is currently no
published evidence demonstrating autoresuscitation under
these conditions [15–17]. Since no interventions will be
made to attempt to restore circulation, cessation of





withdrawal of life 
sustaining therapies
N-2
Cessation of brain function
N-3
Cessation of brain function with no 
possibility to resume
Mechanical ventilation (may occur 
prior to CBI) and neuro-protective 
interventions
Biological events after death
Continuing deterioration and progressive 
loss of brain function despite intervention
Fig. 1 Neurological sequence in the dying process






N-1 Catastrophic brain injury:
continuing deterioration and
progressive loss of brain
function despite intervention
1. Established etiology and/or structural
lesion capable of causing death by
neurological criteria
2. Reduced consciousness (as measured
by GCS 3–5 or FOUR score)
3. Evidence for progressing loss of
brainstem function
1. Neuroimaging that explains the
severity of brain injury
2. Repetition of clinical exams with
trends
3. Demonstration of elevated
intracranial pressure (ICP) by
monitoring
N-2 Cessation of brain function 1. Coma (excluding spinal cord
mediated reflexes)
2. Absence of brainstem reflexes:
• Pupils mid-position or greater and





• Vestibulo-ocular (‘cold caloric’)
• Loss of central drive to breathe
NB: performance of apnoea testing
should be reserved as the last test of
brainstem function
None: cessation of brain function is a
clinical determination
N-3 Cessation of brain function with
no possibility to resume
1. Preconditions fulfilled
2. Confounding conditions excluded or
addressed
3. Refractory to all applied
interventions
4. Intervention not available or
indicated
1. Repetition of the minimum clinical
standard examination
2. Ancillary laboratory tests e.g.
• Demonstration of brain blood flow
or perfusion to be absent
• Refractory intracranial hypertension
as measured by ICP monitoring
• Transcranial Doppler consistent
with absent net flow velocity
• Electrodiagnostic testing (e.g. EEG,
absent evoked potentials)
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A. Cardiorespiratory arrest without CPR 
(end-of-life care / withdrawal / withholding of life sustaining therapies)
B. Cardiorespiratory arrest following termination of CPR 
(hypoxic or primary cardiac arrest)
C-1
Cessation of circulation and breathing 
C-2
Cessation of circulation and breathing with no 
possibility to resume spontaneously 
C-3
Cessation of circulation and breathing with no 
possibility to resume
If CPR provided, resumption of circulation 
theoretically possible
Biological events after death
Fig. 2 Circulatory sequence in
the dying process




the minimum clinical standard)
C-1 Cessation of circulation and
breathing
1. Absent palpable pulse
2. Absent breath sounds
3. Absent heart sounds
4. Absent respiratory effort or chest
wall motion
5. Loss of pulsatile arterial blood
pressure by non-invasive
measurement
6. Coma and fixed dilated pupils
7. Electrical asystole is not required
(pulseless electrical activity is
acceptable)
1. Loss of pulsatile arterial blood
pressure by arterial line monitoring
2. Absence of anterograde blood flow
through the aortic valve on
echocardiography
3. Isoelectric ECG
4. Absence of pulse by Doppler
NB: oxygen saturation pulse oximetry
is an unreliable indicator of absence of
pulsatile circulation
C-2 Cessation of circulation and
breathing with no possibility
to resume spontaneously
1. The persistence of C-1 criteria over a
period of time as confirmed by
continuous observation and
intermittent confirmation including
repetition of this evaluation at the
end of the period. The time period
required is 2–5 min
2. When breathing and circulation
cease following terminated CPR, the
time period to reach the point of ‘‘no
possibility to resume spontaneously’’
is 2–10 min
1. Use of the same tests for a higher
clinical/laboratory standard for C-1
applied after the time interval
required to progress from C-1 to C-2
(2–10 min following termination of
CPR)
C-3 Cessation of circulation and
breathing with no possibility
to resume
1. When CPR will not be provided
(patient fulfils criteria for not
providing CPR) C-3 occurs at the
moment of C-2
2. Following termination of CPR,
including a decision not to reinstitute
CPR, C-3 and C-2 occur at the same
time
1. Nothing in addition to those tests
required for C-2
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breathing and circulation is permanent and the patient
may be determined to be dead (C-2 and C-3 occur at the
same time). In situation B, CPR has been used in an
attempt to restore circulation and respiration but has been
terminated because the patient cannot be revived. Once
the time interval when autoresuscitation is possible has
passed, cessation of breathing and circulation is perma-
nent and the patient may be determined to be dead.
International practice varies with regard to this time
interval between C-1 and C-2. The most common waiting
period is 5 min with a range from 2 to 10 min [18]. The
participants came to consensus on the ‘minimum
acceptable clinical standards’ to test for the cessation of
circulatory function (Table 3).
Integrated neurological and circulatory sequence
in the dying process
The inextricable link between circulation and brain
function means that the neurological and circulatory
sequences integrate at several points in the dying process
of patients who have suffered a circulatory arrest (Fig. 3).
Once circulation and breathing cease (C-1), there is a
short time period between C1 and N2 (\20 s) during
which brain function ceases (N-2) as evidenced by iso-
electric EEG [19–21]. The longer the time period without
oxygenated circulation to the brain (N-2 to N-3) the
progressively higher likelihood that the cessation of brain
function is irreversible, even if oxygenated circulation can
be re-established (either spontaneously or through inter-
vention). The precise time period for the complete
cessation of brain function to be non-resuscitable (through
intervention) is unresolved.
Operational definition of human death
After reviewing the historical taxonomy and definitions of
death, and the neurologic and circulatory sequences in the
dying process that had been previously discussed and
refined, participants came to consensus on an operational
definition of human death, that is, a practical and quan-
tifiable description of the state of human death based on
measurable and observable biomedical standards. Forum
participants agreed on the following operational definition
of death:
Death is the permanent loss of capacity for con-
sciousness and all brainstem functions. This may result
from permanent cessation of circulation or catastrophic
brain injury. In the context of death determination,
‘permanent’ refers to loss of function that cannot resume
spontaneously and will not be restored through inter-
vention [22].
Participants supported avoiding use of anatomically
based terms such as ‘‘brain death’’ or ‘‘cardiac death’’ that
erroneously imply the death of that organ and confuse the
general public, health professionals, and policymakers
(organisms die, while organs cease functioning). Our
operational definition is based on the cessation of function
(the primary and fundamental purpose of an organ that
can be assessed by observation and examination and is
necessary for sustained life) rather than activities (phys-
iologic properties of cells and groups of cells that can be
measured by laboratory means). While the forum partic-
ipants understood that the overwhelming majority of
deaths in the world occur after circulation has ceased, and
many occur outside health care settings, death determi-
nation must focus on the centrality of brain function.
Death is a single phenomenon based on permanent
C-1
Cessation of circulation and breathing 
C-2
Cessation of circulation and breathing with no 
possibility to resume spontaneously 
C-3
Cessation of circulation and breathing with no 
possibility to resume
Biological events after death
N-3
Cessation of brain function with 
no possibility to resume
Cessation of brain 
function with no 
possibility to resume 
spontaneously
N-2
Cessation of brain function 
Increasing likelihood 
over time to progress to N-3
Circulatory Arrest Leading to Death
Fig. 3 Physiological sequences
in the dying process: integrated
neurological and circulatory
sequence (applies to patients
suffering a circulatory arrest)
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cessation of brain function (loss of capacity for con-
sciousness and brainstem reflexes), which occurs along
two pathways: (1) permanent absence of circulation or (2)
subsequent to a catastrophic brain injury, each discerned
through a specific set of medical criteria and clinical and
laboratory tests—two entrances, one end point.
Conclusions
This report describes the initial phase in an international
process to develop guidelines and agree upon an opera-
tional definition for determining death, based on the
cessation of neurological and circulatory functions. Ple-
nary discussions resulted in consensus on seven key areas:
1. Death is determined primarily using clinical criteria
based on direct observation or examination of the
patient, once preconditions have been fulfilled and
confounding conditions excluded.
2. The physiological sequences by which circulatory and
neurological functions cease, leading up to the moment
of death, were set forth to clarify the critical events
that occur following a catastrophic injury or illness.
3. Clinical tests that constitute the minimum clinical
standard for the determination of death were defined
for both the neurological and the circulatory sequences.
Preconditions and confounding conditions that may
impede or invalidate death diagnosis were also specified.
4. Certain ancillary and/or complementary laboratory
tests may be useful in situations in which clinical
testing cannot be performed or when confounding or
special conditions are present; limitations to using
certain of these tests in death determination mean that
further research is required to ensure their reliability.
5. A set of precise terminology, which aims to improve
clarity in death determination discussions and debate,
was agreed upon.
6. An operational definition of human death, based on
measurable biomedical standards, was proposed. Par-
ticipants supported avoiding use of anatomically based
terms such as ‘‘brain death’’ or ‘‘cardiac death’’ that
erroneously imply the death of an organ. Emphasis
was placed on the cessation of neurological or
circulatory function, and the centrality of brain func-
tion for determination of death. ‘‘Death occurs when
there is permanent loss of capacity for consciousness
and loss of all brainstem functions. This may result
from permanent cessation of circulation or cata-
strophic brain injury. In the context of death
determination, ‘permanent’ refers to loss of function
that cannot resume spontaneously and will not be
restored through intervention.’’ This definition is based
on the cessation of function (the primary and
fundamental purpose of an organ that can be assessed
by observation and examination and is necessary for
sustained life) rather than activities (physiologic
properties of cells and/or groups of cells that can be
measured by laboratory means).
7. In order to complete the elaboration of an operational
definition of human death that could be used in
countries around the world, a broader group of
international stakeholders will be needed to develop
clinical practice guidelines, based on comprehensive,
systematic reviews and grading of existing evidence.
Acknowledgments The authors would like to thank Strachan
Tomlinson for their invaluable process consultation, Dr. Francis
Delmonico for his role as international advisor, and Dr. Michael
DeVita for review of the manuscript. We would like to acknowl-
edge Dr. Martı´ Manyalich, who represented Spain as a meeting
participant, but subsequently requested removal from the author-
ship list. Funding for this meeting has been provided by Canadian
Blood Services. Canadian Blood Services is a national, not-for-
profit charitable organization that manages the supply of blood and
blood products in all provinces and territories in Canada (with the
exception of Quebec) and oversees the OneMatch Stem Cell and
Marrow Network. Canadian Blood Services also received a man-
date in 2008 for national activities related to organ and tissue
donation and transplantation (OTDT), which includes development
of leading practices, public awareness, and education, system per-
formance measurement, and establishing patient registries.
Canadian Blood Services is not responsible for the management or
funding of any Canadian Organ Procurement Organizations (OPOs)
or Transplant Programs. Canadian Blood Services is an agency that
receives its funding from the provincial and territorial Ministries of
Health and the federal government, through Health Canada. The
following organizations kindly provided travelling expenses for
their representatives to attend this meeting: Australia and New
Zealand Intensive Care Society, European Society of Intensive
Care Medicine, International Federation of Emergency Medicine,
International Pan Arab Critical Care Medicine Society, Neurocrit-
ical Care Society, Society of Critical Care Medicine, World
Federation of Neurology, World Federation of Neurosurgical
Societies, World Federation of Pediatric Intensive and Critical Care
Societies, World Federation of Societies of Intensive and Critical
Care Medicine. It is recognized that pursuit of best practices related
to death determination is most often administered by those acute
care practitioners who are also involved with deceased donation
practices and policy. Given concerns about potential conflict of
interest, there has been a deliberate effort to exclude the involve-
ment of transplant programs in this process. In support of the
overall planning process, the following groups have been involved
in their respective roles: The International Society for Organ
Donation and Procurement (ISODP). The mission of ISODP
includes promotion of high ethical standards in transplantation, as
both donor and recipient are members of a community where equity
and justice are equally important to success. The development of
international guidelines for determination of death supports this
goal. ISODP provided travel funds for its representative. No other
funding for the meeting has been received from ISODP. The
Transplantation Society (TTS), together with the WHO, has played
a role in moving the international dialogue on transplant tourism
forward. They have been active in the development of the Istanbul
and Madrid accords and as a result have a breadth and depth of
knowledge of practices across the globe. Francis Delmonico, their
president, has provided counsel as part of the international advisory
committee but was not a participant at the meeting. No funding for
the meeting has been received from TTS.
795
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction in
any medium, provided the original author(s) and the source are
credited.
Appendix 1: Forum committees, speakers,
and organizations
Forum planning committee: Dr. Sam Shemie (forum
chair), Dr. Andrew Baker, Ms. Laura Hornby, Ms. Dor-
othy Strachan, Dr. Jeanne Teitelbaum, Ms. Sylvia
Torrance, Ms. Kimberly Young.
Forum international advisory committee: Dr. Sam
Shemie (forum chair), Dr. James Bernat, Professor
Alexander Capron, Dr. Frank Delmonico, Dr. Luc Noel.
Forum research group: Dr. Andrew Baker, Ms. Laura
Hornby, Ms. Dorothy Strachan, Dr. Jeanne Teitelbaum,
Dr. Tong Kiat Kwek, Dr. Alexander Manara.
Expert speakers: Dr. Sam Shemie—Challenge
address; Dr. Luc Noel—International perspectives; Dr.
Eelco Wijdicks—Death and the brain; Dr. James Ber-
nat—Death and the circulation; Prof. Alexander M.
Capron—Historical review of the definition of death; Dr.
Charles Sprung—Building global agreement around
complex practices; Dr. Margaret Harris—WHO guide-
lines development process.
Participating organizations: Canadian Blood Services;
Australia and New Zealand Intensive Care Society;
Canadian Critical Care Society; European Society of
Intensive Care Medicine; International Federation of
Emergency Medicine; International Pan Arab Critical
Care Medicine Society; International Society for Organ
Donation and Procurement; Neurocritical Care Society;
Society of Critical Care Medicine; United Kingdom
Faculty of Intensive Care Medicine; University of Ottawa
Loeb Chair and Research Consortium in Organ and Tis-
sue Donation; World Federation of Neurology; World
Federation of Neurosurgical Societies; World Federation
of Pediatric Intensive and Critical Care Societies; World
Federation of Societies of Intensive and Critical Care
Medicine; World Health Organization.
Appendix 2: International Guidelines
for Determination of Death phase 1 participants
Dr. Tamer Abdelhak, International Pan Arab Critical Care
Medicine Society; Dr. Sadek Beloucif, France; Dr.
Mohammed Salah Ben Ammar, Tunisia; Dr. Andrew
Baker, Canadian Critical Care Society; Dr. James L.
Bernat, Department of Neurology, Geisel School of
Medicine at Dartmouth; Dr. Peter Black, World Federa-
tion of Neurosurgical Societies; Dr. Thomas Bleck,
Society of Critical Care Medicine; Dr. Romuald Bo-
hatyrewicz, Poland; Prof. Alexander M. Capron,
Professor of Law and Medicine, University of Southern
California; Dr. Giuseppe Citerio, European Society of
Intensive Care Medicine; Prof. Geoff Dobb, Australia and
New Zealand Intensive Care Society; Laura Hornby,
Loeb Chair and Research Consortium in Organ and Tis-
sue Donation; Dr. Waleed Jasim, International Pan Arab
Critical Care Medicine Society; Dr. Edgar Jimenez,
World Federation of Societies of Intensive and Critical
Care Medicine; Dr. Gu¨nter Kirste, International Society
for Organ Donation and Procurement; Dr. Niranjan Kis-
soon, World Federation of Pediatric Intensive and Critical
Care Societies; Dr. Tong Kiat Kwek, Singapore; Dr.
Alexander Manara, UK Faculty of Intensive Care Medi-
cine; Dr. Luck Noel, World Health Orgnization; Dr. Sam
D. Shemie; Dr. Mikhail Sinkin, Moscow Mobile Neuro-
diagnostic Group, Russia; Prof. Charles L. Sprung, Israel;
Dr. Gene Sung, Neurocritical Care Society; Dr. John
Tallon, International Federation of Emergency Medicine;
Dr. Jeanne Teitielbaum, Canada; Ms Sylvia Torrance,
Canadian Blood Services; Dr. Eelco Wijdicks, USA; Dr.
G. Bryan Young, World Federation of Neurology.
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